Scancell (LON:SCLP) Shares Cross Above 50 Day Moving Average of $9.90

Shares of Scancell Holdings plc (LON:SCLPGet Free Report) passed above its 50 day moving average during trading on Monday . The stock has a 50 day moving average of GBX 9.90 ($0.13) and traded as high as GBX 10.50 ($0.13). Scancell shares last traded at GBX 10.33 ($0.13), with a volume of 631,989 shares trading hands.

Scancell Stock Performance

The company has a current ratio of 8.63, a quick ratio of 13.01 and a debt-to-equity ratio of 61.41. The company has a market capitalization of £94.76 million, a P/E ratio of -1,020.00 and a beta of 0.37. The business has a 50 day moving average price of GBX 9.90 and a 200 day moving average price of GBX 10.72.

About Scancell

(Get Free Report)

Scancell Holdings plc, a clinical stage biopharmaceutical company, engages in the discovery and development of novel immunotherapies and vaccines for the treatment of cancer and infectious disease. Its product candidates include SCIB1, an ImmunoBody cancer vaccine that is in Phase II for the treatment of metastatic melanoma; and SCIB2/iSCIB2 vaccine, which is under evaluation for the treatment of patients with solid tumors, including non-small cell lung cancer.

Further Reading

Receive News & Ratings for Scancell Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Scancell and related companies with MarketBeat.com's FREE daily email newsletter.